论文部分内容阅读
目的:探讨丹红注射液治疗不稳定型心绞痛(UAP)的临床疗效。方法:将120例临床上确诊为冠心病心绞痛不稳定的患者随机分为两组,每组各60例。两组均常规应用肠溶阿司匹林、β受体阻滞剂或钙拮抗剂、硝酸酯类制剂、他汀类药物,治疗组在其基础上加用丹红注射液20mL加入5%葡萄糖溶液或生理盐水250mL中静脉滴注,每日1次,共用15天。结果:丹红注射液治疗组控制心绞痛有效率为95.00%,改善心电图有效率为80.00%,疗效优于对照组,两组比较差异有统计学意义(P<0.05)。结论:常规治疗的基础上加用丹红注射液治疗冠心病不稳定心绞痛疗效显著。
Objective: To investigate the clinical efficacy of Danhong injection in the treatment of unstable angina pectoris (UAP). Methods: 120 cases of clinically diagnosed unstable angina pectoris patients were randomly divided into two groups, 60 cases in each group. Both groups were routinely used enteric-coated aspirin, β-blockers or calcium antagonists, nitrates, statins, the treatment group on the basis of the use of Danhong injection 20mL adding 5% glucose solution or saline 250mL intravenous infusion, once daily, sharing 15 days. Results: The effective rate of angina pectoris treated by Danhong injection group was 95.00%, and the effective rate of electrocardiogram improvement was 80.00%. The curative effect was better than that of the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: The conventional treatment based on the use of Danhong injection of unstable angina pectoris has a significant effect.